Supporting people with type 2 diabetes in effective use of their medicine through a system comprising mobile health technology integrated with clinical care compared with usual care: a randomised controlled trial
Type 2 diabetes is a common disease, however, the risk of serious complications can be reduced through use of effective treatments and active self-management. People are often concerned about their medicines and face difficulties in taking them regularly. We have developed brief mobile-phone based text messages that aim to support patients’ self-management of type 2 diabetes in the use of medications and other aspects of self-management. The aim of this trial is to compare the effectiveness and cost effectiveness of brief messaging to support patients with type 2 diabetes taking diabetes medicine (glucose, blood pressure, or lipid lowering) in reducing risk factors for diabetes complications, with usual care.
This is a randomised controlled trial.
Who can take part?
Participant is willing and able to give informed consent.
- Male or female, ≥35 years of age.
- Type 2 diabetes.
- Taking oral glucose lowering treatment, blood pressure lowering treatment or lipid lowering treatment (diabetes treatments) either alone or in combination
- Has access to a UK registered mobile phone and is able, if necessary, with help
- (e.g. relative, friend, neighbour), to send, understand and retrieve brief SMS
- text-messages in the English language.
- The participant's practice is participating in the trial.
This research trial is currently closed to recruitment
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.